TRT personal experience videos: what the science says vs. the hype

What did @markanthony.bee actually say?

The creator describes going from 143 to 183 pounds in "a couple of months" on TRT, attributing symptoms like fatigue, low libido, and slow hair growth as his reasons for starting therapy. He also claims that anyone starting testosterone "needs to get on blockers" to prevent gynecomastia, warns that "testosterone rage is super real," and announces he just started MK-677, calling it "a peptide that really just induces the growth hormone." He positions himself as someone other people should ask for TRT advice.

He's sharing personal experience, which is fine. The problem is he's also issuing what sound like clinical directives to strangers on the internet, which is not fine.

Does the science back this up?

Partially. The symptoms he describes, fatigue, low libido, and slow hair growth, can be associated with hypogonadism, and TRT is an established treatment for that. But a 40-pound gain in a couple of months is not consistent with TRT alone, and the blanket claim that everyone needs an estrogen blocker is not what the clinical literature says.

Regarding estrogen management: testosterone does aromatize to estradiol, and in some patients estradiol rises enough to cause gynecomastia. But prophylactic aromatase inhibitor (AI) use for all TRT patients is not standard of care. A 2017 review by Ramasamy et al. in the Journal of Urology notes that AI use should be targeted, not universal, and that suppressing estradiol too aggressively causes its own problems including bone density loss and mood disturbance. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) do not recommend routine AI co-prescription with TRT.

As for MK-677: it is not approved by the FDA for any indication, is not legally classified as a peptide therapeutic, and evidence for its safety in humans is limited to small, short-duration trials.

What did they get wrong (or right)?

He got the mechanism roughly right. Exogenous testosterone does aromatize to estradiol, and elevated estradiol can contribute to gynecomastia. That part is real. He also correctly notes that not everyone is a candidate for TRT and that bloodwork is necessary before starting, which is more than a lot of TRT influencers say.

What he got wrong is the universal blocker claim. Telling viewers "if your med spot does not give you blockers, you need to go to another" is medically irresponsible. Some men on TRT have no significant estradiol elevation and do not need an AI. Blanket AI use can lead to low estradiol, which causes joint pain, depression, reduced libido, and cardiovascular risk. He is also self-managing with what he describes as taking a blocker when he "feels" rage coming on, which is not how these medications are meant to be dosed.

The 40-pound gain claim also deserves scrutiny. TRT in genuinely hypogonadal men produces meaningful but not dramatic weight changes over months. A gain of that magnitude in "a couple of months" is inconsistent with TRT pharmacology and raises questions about what else may be contributing.

What should you actually know?

TRT is a legitimate medical treatment for clinically diagnosed hypogonadism, not a general performance enhancement tool. Diagnosis requires documented low testosterone on at least two morning blood draws plus symptoms. Estrogen management during TRT is individualized, not automatic. Some patients need an aromatase inhibitor, many do not, and that determination should come from a clinician reviewing your labs, not a TikTok video.

MK-677, also called ibutamoren, is not an approved drug or regulated therapeutic. It is a ghrelin receptor agonist being studied for specific conditions, but it is not cleared for general use. The FDA has specifically flagged it as a compound that cannot legally be sold as a dietary supplement. Framing it as a harmless peptide that "induces growth hormone" glosses over real unknowns including potential effects on insulin sensitivity and long-term safety.

• TRT requires a clinical diagnosis, not just symptoms you recognize from a video.
• Aromatase inhibitors are not universal TRT companions. Overuse causes serious side effects.
• MK-677 is not FDA-approved and has limited human safety data. It is not a supplement.
• A 40-pound gain in two months suggests more variables than TRT alone.

Should you follow this creator's advice?

Follow his experience as a data point. Do not follow his clinical directives. He means well and he's more careful than most TRT influencers about mentioning bloodwork and candidacy screening. But he is not a clinician, and statements like "you need to get on blockers" or asking strangers to message him TRT questions put real people at risk of self-prescribing medications that require monitoring. If you are interested in TRT, work with a licensed provider who will run baseline labs, monitor your hematocrit, lipid panel, and estradiol, and adjust your protocol based on your actual numbers, not what worked for someone else.